Medicine and Dentistry
PARP Inhibitor
100%
Prostate Cancer
100%
Cas9
100%
Clustered Regularly Interspaced Short Palindromic Repeat
100%
PARP1
50%
Castration Resistant Prostate Cancer
50%
Autophagy
37%
Olaparib
25%
Veliparib
12%
Niraparib
12%
Cross Resistance
12%
RNA Sequence
12%
Recurrent Disease
12%
Gene Mutation
12%
Therapy Resistance
12%
Identified Patient
12%
Neoplasm
12%
Cancer Cell
12%
DNA Repair
12%
Biochemistry, Genetics and Molecular Biology
CRISPR/Cas9
100%
Poly ADP Ribose Polymerase
100%
Poly ADP Ribose Polymerase
100%
PARP1
57%
Autophagy
42%
Cross Resistance
14%
RNA Sequence
14%
YWHAE
14%
Gene Mutation
14%
Cancer Cell
14%
LNCaP
14%
DNA Repair
14%
GAS5
12%